Curative exits a major Salesforce CRM contract, rolling out an in-house AI CRM for healthcare operations

Curative, a healthcare-focused organization, said it is ending a major contract for customer relationship management software from Salesforce, according to a report published by Yahoo Finance on Aug. 11, 2026. The company is instead rolling out its own in-house CRM platform designed specifically for its operations, with an emphasis on using AI to support day-to-day healthcare workflows.

The report frames the shift as a tradeoff between outsourcing CRM capabilities to a large vendor versus keeping the system internal. Curative cited cost and speed advantages from its internal platform compared with the previous Salesforce arrangement, describing the move as a way to accelerate implementation and reduce spending.

CRM systems are software used by organizations to manage interactions with customers and partners, track information and communications, and coordinate processes across teams. For healthcare organizations, CRM-like workflows often overlap with patient-facing or partner-facing coordination, scheduling, inquiry handling, and internal reporting, even when the organization’s core technology stack includes other specialized platforms.

While the report indicates that Curative is deploying an AI-powered in-house CRM, it does not provide full implementation details, such as the timeline for rollout, whether the system is limited to specific departments, or how broadly it will replace Salesforce functions. It also does not clarify the size of the Salesforce contract that is being ended, nor whether any other Salesforce products beyond CRM were involved in the decision.

Salesforce’s customer relationship management suite is one of its best-known products, and the broader Salesforce ecosystem is widely used by enterprises to unify sales, service, marketing, and other customer operations under one platform. In practice, transitions away from a major Salesforce CRM agreement can be operationally complex because companies often need to migrate data, retrain users, and rebuild integrations with other systems.

Curative’s stated rationale also highlights a broader industry tension: enterprise software buyers increasingly evaluate internal AI-enabled systems against vendor platforms on metrics like time to deploy, customization, and ongoing costs. As AI capabilities become more embedded across enterprise tools, organizations may seek architectures that they can adjust quickly, particularly when requirements are specialized and change frequently.

Even so, the information publicly available in the cited report is not enough to determine what functionality Curative preserved, what it re-engineered, or how performance will be measured after the transition. It is also unclear whether Curative’s in-house CRM is developed entirely in-house, built with partners, or supported by specific third-party AI components.

What to watch next is whether Curative provides additional disclosures about the rollout scope and the operational outcomes it expects from its in-house AI CRM. For Salesforce, the key question is whether this will remain an isolated customer decision or becomes part of a larger pattern of CRM migrations as healthcare and other sectors benchmark vendor costs and deployment speed against internal alternatives.